Antios Therapeutics develops innovative therapies to treat and cure viral diseases. Its lead drug candidate, ATI-2173, aims to potentially cure chronic Hepatitis B (HBV).
Antios Therapeutics develops innovative therapies to treat and cure viral diseases. Its lead drug candidate, ATI-2173, aims to potentially cure chronic Hepatitis B (HBV).